<header id=056994>
Published Date: 2022-06-28 16:22:12 EDT
Subject: PRO/ALL> New in IJID (06): June 2022
Archive Number: 20220628.8704130
</header>
<body id=056994>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (06): JUNE 2022
*******************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: June 2022
Source: IJID [edited]
https://www.ijidonline.com/


Editorial
---------
The show is not over -- wild-type polio in Malawi is a wake-up call and an opportunity for elimination efforts
McCarthy et al.
Int J Infect Dis. 2022; 119: 32-33
https://doi.org/10.1016/j.ijid.2022.03.004

Coronavirus (COVID-19) collection
---------------------------------
Reviews
-------
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A systematic review and meta-analysis
Kim et al.
Int J Infect Dis. 2022; 119: 130-139
https://doi.org/10.1016/j.ijid.2022.03.034

Clinical
--------
Decreased severity of the omicron variant of concern: further evidence from Italy
Divino et al.
Int J Infect Dis. 2022; 119: 21-23
https://doi.org/10.1016/j.ijid.2022.03.023

Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19
Jackson et al.
Int J Infect Dis. 2022; 119: 47-52
https://doi.org/10.1016/j.ijid.2022.03.044

Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study
Klopfenstein et al.
Int J Infect Dis. 2022; 119: 114-116
https://doi.org/10.1016/j.ijid.2022.03.053

Diagnostics
-----------
Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting
Jegerlehner et al.
Int J Infect Dis. 2022; 119: 38-40
https://doi.org/10.1016/j.ijid.2022.03.037

Immunity
Parasites Protect from Severe COVID-19. Myth or Reality?
Makram et al.
Int J Infect Dis. 2022; 119: 117-118
https://doi.org/10.1016/j.ijid.2022.03.027

Vaccines
--------
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
Inada et al.
Int J Infect Dis. 2022; 119: 18-20
https://doi.org/10.1016/j.ijid.2022.03.017

Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: An observational study
Suah et al.
Int J Infect Dis. 2022; 119: 69-76
https://doi.org/10.1016/j.ijid.2022.03.028

Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
Li et al.
Int J Infect Dis. 2022; 119: 87-94
https://doi.org/10.1016/j.ijid.2022.03.029

The impact of COVID-19 vaccines on the case fatality rate: The importance of monitoring breakthrough infections
di Lego et al.
Int J Infect Dis. 2022; 119: 178-183
https://doi.org/10.1016/j.ijid.2022.03.059

Effect of a two-dose vs three-dose vaccine strategy in residential colleges using an empirical proximity network
Hambridge et al.
Int J Infect Dis. 2022; 119: 210-213
https://doi.org/10.1016/j.ijid.2022.04.007

Epidemiology
------------
Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
Ghosh et al.
Int J Infect Dis. 2022; 119: 111-113
https://doi.org/10.1016/j.ijid.2022.03.042

Public health
-------------
Antimicrobial use fell substantially in Japan in 2020 -- The COVID-19 pandemic may have played a role
Ono et al.
Int J Infect Dis. 2022; 119: 13-17
https://doi.org/10.1016/j.ijid.2022.03.019

Unwillingness or reluctance of Palestinians to get COVID-19 vaccine: the reasons behind it and how to persuade them
Abu-Odah et al.
Int J Infect Dis. 2022; 119: 53-55
https://doi.org/10.1016/j.ijid.2022.03.039

Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste
Arkell et al.
Int J Infect Dis. 2022; 119: 80-86
https://doi.org/10.1016/j.ijid.2022.03.043

Case reports
------------
Varicella-zoster virus (VZV) meningitis in an immunocompetent adult following BNT162b2 mRNA COVID-19 vaccination: A case report
Medhat et al.
Int J Infect Dis. 2022; 119: 184-186
https://doi.org/10.1016/j.ijid.2022.04.001

Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
Buranasakda et al.
Int J Infect Dis. 2022; 119: 214-216
https://doi.org/10.1016/j.ijid.2022.03.055


Non-COVID-19 collection
------------------------
Perspective
-----------
Towards typhoid fever elimination
Khanam et al.
Int J Infect Dis. 2022; 119: 41-43
https://doi.org/10.1016/j.ijid.2022.03.036

Reviews
-------
Risk factors for contracting invasive meningococcal disease and related mortality: A systematic literature review and meta-analysis
Dubey et al.
Int J Infect Dis. 2022; 119: 1-9
https://doi.org/10.1016/j.ijid.2022.03.032

A systematic review of brain imaging findings in neurological infection with Japanese encephalitis virus compared with dengue virus
Pichl et al.
Int J Infect Dis. 2022; 119: 102-110
https://doi.org/10.1016/j.ijid.2022.03.010

Antimicrobial resistance through the lens of one health in Ethiopia: A review of the literature among humans, animals, and the environment Fujita et al.
Int J Infect Dis. 2022; 119: 120-129
https://doi.org/10.1016/j.ijid.2022.03.041

Lassa virus infection: A summary for clinicians
Raabe et al.
Int J Infect Dis. 2022; 119: 187-200
https://doi.org/10.1016/j.ijid.2022.04.004

Bacterial infections
--------------------
Prognostic factors of OXA-48 carbapenemase-producing _Klebsiella pneumoniae_ infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study
Corbella et al.
Int J Infect Dis. 2022; 119: 59-68
https://doi.org/10.1016/j.ijid.2022.03.025

Epidemiology of multidrug resistance among _Salmonella enterica_ serovars Typhi and Paratyphi A at a tertiary pediatric hospital in India over a decade; in-silico approach to elucidate molecular mechanism of quinolone resistance
Manoharan et al.
Int J Infect Dis. 2022; 119: 146-149
https://doi.org/10.1016/j.ijid.2022.03.050

Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger
Andersen et al.
Int J Infect Dis. 2022; 119: 163-171
https://doi.org/10.1016/j.ijid.2022.03.047

_Sphingomonas paucimobilis_ bloodstream infection is a predominantly community-onset disease with significant lethality
Laupland et al.
Int J Infect Dis. 2022; 119: 172-177
https://doi.org/10.1016/j.ijid.2022.03.060

Impact of bacterial phenotypic variation with bacteriophage therapy: A pilot study with prosthetic joint infection isolates
Doub et al.
Int J Infect Dis. 2022; 119: 44-46
https://doi.org/10.1016/j.ijid.2022.03.022

Regional differences in antibiotic-resistant Enterobacterales urine isolates in the United States: 2018-2020
Aronin et al.
Int J Infect Dis. 2022; 119: 142-145
https://doi.org/10.1016/j.ijid.2022.03.052

Viral infections
----------------
Impact of glycemia and insulin treatment in fatal outcome of severe fever with thrombocytopenia syndrome
Ge et al.
Int J Infect Dis. 2022; 119: 24-31
https://doi.org/10.1016/j.ijid.2022.03.038

Development, verification, and validation of a RT-qPCR-based protocol for yellow fever diagnosis
Rampazzo et al.
Int J Infect Dis. 2022; 119: 34-37
https://doi.org/10.1016/j.ijid.2021.12.361

Nosocomial outbreak of severe fever with thrombocytopenia syndrome among healthcare workers in a single hospital in Daegu, Korea
Bae et al.
Int J Infect Dis. 2022; 119: 95-101
https://doi.org/10.1016/j.ijid.2022.03.048

Superinfection is associated with short-term outcome and mortality in viral respiratory tract infections during the fall-winter seasons 2016-2018 in the Greater Paris area: the SUPERFLUOUS study: outcomes of viral infections
Davido et al.
Int J Infect Dis. 2022; 119: 217-224
https://doi.org/10.1016/j.ijid.2022.04.008

Fungal infections
-----------------
Impact of routine bedside infectious diseases service on clinical management and prognosis of patients with _Candida_ fungemia -- an example for antifungal stewardship at university level in Germany
Dudakova et al.
Int J Infect Dis. 2022; 119: 150-159
https://doi.org/10.1016/j.ijid.2022.03.054

Disseminated histoplasmosis and erythrophagocytosis in an immunocompromised host: the role of bone marrow evaluation for prompt diagnosis of invasive fungal infections
Lage et al.
Int J Infect Dis. 2022; 119: 10-12
https://doi.org/10.1016/j.ijid.2022.03.031

Vaccine preventable infections
------------------------------
Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns
Ho et al.
Int J Infect Dis. 2022; 119: 201-209
https://doi.org/10.1016/j.ijid.2022.04.005

Case reports
------------
_Plasmodium malariae_ after successful treatment of _P. falciparum_ malaria with artemether-lumefantrine
Tournoy et al.
Int J Infect Dis. 2022; 119: 56-58
https://doi.org/10.1016/j.ijid.2022.03.045

Potential impact of cell-free DNA blood testing in the diagnosis of sepsis
Ziegler et al.
Int J Infect Dis. 2022; 119: 77-79
https://doi.org/10.1016/j.ijid.2022.03.030

Application of noninvasive positive pressure ventilation to respiratory complications of severe tetanus: a case report
Imanishi et al.
Int J Infect Dis. 2022; 119: 160-162
https://doi.org/10.1016/j.ijid.2022.04.003

Variations in the appearance of posterior pharyngeal wall follicles in individuals with viral upper respiratory infections according to the virus and the stage of infection: A case series
Takahashi et al.
Int J Infect Dis. 2022; 119: 140-141
https://doi.org/10.1016/j.ijid.2022.03.056

Corrigendum
-----------
Corrigendum to 'Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis' [International Journal of Infectious Diseases, Volume 116 (2022) P59-67]
Jahan et al.
Int J Infect Dis. 2022; 119: 119-119
https://doi.org/10.1016/j.ijid.2022.03.051

--
Communicated by:
ProMED

[The new impact factor for the IJID has just been released and is 12.7. The IJID is now ranked as the 13th out of 94 infectious disease journals.

Another good news is that IJID Regions has been accepted and will appear in ProMED sometime during July 2022, meaning that all previously published papers in IJID Regions will be in PubMed. - Mod.EP]
See Also
New in IJID (05): May 2022 20220505.8703058
New in IJID (04): April 2022 20220405.8702421
New in IJID (03): March 2022 20220304.8701795
New in IJID (02): February 2022 20220206.8701298
New in IJID (01): December 2021 20220109.8700756
2021
----
New in IJID (11): November 2021 20211205.8700079
New in IJID (10): October 2021 20211107.8699506
New in IJID (09): September 2021 20211007.8698901
New in IJID (08): August 2021 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
and other items in the archives
.................................................ep/mj/ml
</body>
